We demonstrated that Evr exhibited anti-cancer properties by inhibiting the activation of the PI3K/AKT/mTOR pathway to regulate glucose metabolism, tube formation, cell migration, and apoptosis in pancreatic cancer cells. The gene discussed is MTOR; the disease is familial pancreatic carcinoma.